AstraZeneca announced that the EC has approved Qtern tablets for the treatment of type 2 diabetes in all 28 EU...
Read moreAstraZeneca announced that the Phase III AURA3 trial met its primary endpoint, demonstrating superior progression-free survival (PFS) compared to standard...
Read more- Approval includes toric version of symfony iol for people with astigmatism- lenses provide high-quality continuous vision so patients can...
Read more• Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade...
Read moreAbbott announced that Health Canada has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available...
Read moreSandoz, a Novartis division and leader in biosimilars, announced today that the US FDA Advisory Committee recommended approval of its...
Read moreJanssen Pharmaceuticals, Inc one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced today that the U.S. Food...
Read moreEli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the...
Read moreBayer and X-Chem, Inc focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics,...
Read moreAbbVie a global biopharmaceutical company, announced that the U.S. FDA granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
Notifications
